AAAl-Mukhtar Yahuza Adamu

Al-Mukhtar Yahuza Adamu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Al-Mukhtar Yahuza Adamu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?

    by Mansur Aliyu, Ali Akbar Saboor-Yaraghi, Mohamad Ali Sahraian, Farshid Noorbakhsh, Al-Mukhtar Yahuza Adamu, Alhassan Abdullahi Sharif, Zainab Aliyu Abdulqadir

    The emerging role of Innate Lymphoid Cells (ILCs) in the pathogenesis and regulation of Multiple Sclerosis (MS), a complex neuroinflammatory autoimmune disease, has been increasingly recognized. Once identified only for activities conducted at barrier surfaces, ILCs are now understood to be important modulators of inflammation and tissue repair within the Central Nervous System (CNS). This review aims to elucidate the ‘two sides of the coin’ nature of ILCs in MS. ILCs are implicated in pathogenesis by driving neuroinflammation through pro-inflammatory cytokines, contributing to the formation of ectopic meningeal lymphoid follicles, and modulating meningeal immune system interactions. In contrast, certain ILC subsets confer protective effects by secreting anti-inflammatory cytokines and promoting tissue homeostasis. Recent experimental and clinical studies have demonstrated the complex balance and alteration of ILC responsiveness at various stages of MS. We focused on the importance of ILC subset determination, including their dependence on key cytokine signaling pathways and their critical role in the gut-CNS axis, a pivotal mediator of systemic immunity in MS. Moreover, the potential for ILC pathway targeting, either by modulating cytokine networks or modifying the microbiota, is discussed as a promising avenue for restoring immune balance, promoting neuroprotection and suppressing ILC-driven inflammation. Despite the challenges presented by ILC plasticity and diversity, elucidating ILC biology offers a clear path toward developing precise immunomodulatory strategies aimed at halting disease progression and promoting CNS repair in patients with MS.


  • Open Access

    Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria

    by Khadija Muhammad Kawu, Muhammad Ibrahim Getso, Taysir Ramadan, Alhassan Abdullahi Sharif, Kanishka Hrishi Das, Al-Mukhtar Yahuza Adamu, Mansur Aliyu

    Otomycosis is the commonest cause of otitis externa seen in otorhinolaryngology clinics, especially in tropical and subtropical regions of the world. Diagnosis is usually made clinically and confirmed by laboratory identification of fungal elements. We conducted a cross-sectional and hospital-based epidemiological study that aimed to determine the prevalence, distribution and antifungal susceptibility profile of common aetiologic agents of otomycosis in Kano, northwestern Nigeria. We collected clinical samples from 300 patients who presented with symptoms of external ear infection, out of which 117 subjects (39.0%) were mycologically positive. Aspergillus species were the predominant isolate, with 90 (77.0%), followed by Candida species at 27 (23.0%). Otomycosis accounts for 39% of otitis externa seen in our center, mostly presenting with pruritus and otalgia. Raising the awareness of the general population to the predisposing factors may significantly reduce the incidence of otomycosis.

  • Open Access

    Detection of antimalarial drug resistance polymorphisms in Plasmodium falciparum chloroquine resistance transporter and Plasmodium falciparum multidrug resistance 1 genes of Plasmodium falciparum found in Kano State, Nigeria

    by Al-Mukhtar Yahuza Adamu, Olayeni Stephen Olonitola, Helen Ileigo Inabo, Ahmad Babangida Suleiman

    Objectives: In 2018, malaria claimed an estimated 380,000 lives in African region, with Nigeria accounting for 24.0% (91,368) of malaria deaths from the region. Mutations in Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and P. falciparum multidrug resistance 1 (Pfmdr-1) genes had reduced the effective use of artemisinin combination therapy through the development of resistance to these antimalarial agents. Our study set out to determine the antimalarial drug resistance polymorphisms in Pfcrt and Pfmdr-1 genes of P. falciparum isolates among patients in Kano State, Nigeria. Material and Methods: Malaria positive samples were collected across the three senatorial districts of Kano State. The samples were amplified using nested polymerase chain reaction to detect the Pfcrt and Pfmdr-1 genes. The amplicons were sequenced and bioinformatic analysis was done using CLC Sequence viewer 8.0 and BioEdit sequence alignment editor to detect the single-nucleotide polymorphisms. Results: In the Pfcrt gene, CVIET haplotype was seen in 26.2% of the samples while only two samples showed the 86Y mutation in the Pfmdr-1 gene. All the 86Y mutations and majority of the CVIET haplotypes were detected in the patients from rural settings where some of them noted that they consumed modern and traditional (herbs) antimalarial agents. One sample was observed to have the CVIET haplotype and N86Y mutation while the other five CVIET haplotypes were seen in five separate samples. A new mutation V62A was found in the Pfmdr-1 gene as observed in one of the sample. Conclusion: It is imperative to ensure the rational use of the right antimalarial agents and employ continuous resistance surveillance/mapping to ensure synergy in malaria containment and elimination strategies.

  • Open Access

    Effects of Malaria Infection on Haematological Parameters among Patients in Kano State, Nigeria

    by A. Y. Adamu, O. S. Olonitola, H. I. Inabo, A. B. Suleiman

    Destruction and alteration of blood cells, especially erythrocytes, are the common devastating effects of malaria infection. This leads to haematological changes often characterised by anaemia, thrombocytopaenia, and leucocytosis or leucopaenia. The aim of this study is to assess the effects of malaria infection on erythrocytes and leucocytes with associated risk factors. 200 malaria-positive patients were enrolled in this study. The patients’ haematological parameters and parasitemia levels were assessed. Plasmodium falciparum was detected in 197 (98.5%) patients as the most predominant species, while 3 patients had mixed infection. A mean parasite density of 11,496 parasites/µL was observed, with the majority of the patients showing parasitaemia of 50,000 parasites/µL. The mean white blood cells count, neutrophils, and eosinophils count in malaria-infected patients were seen to be increased compared to the malaria-negative control group. Haemoglobin concentration, haematocrit level, and mean cell haemoglobin were, however, seen to be lower in the malaria-positive patients than the control group. The majority of the patients had hypochromia indicated by lower mean cell haemoglobin, which increases with the severity of malaria infection. Haematological changes can be used to depict the severity of malaria infection among all age groups.

  • Open Access

    Setting a Nigeria national malaria operational research agenda: the process

    by Olufemi Ajumobi, Perpetua Uhomoibhi, Pamela Onyiah, Obafemi Babalola, Salami Sharafadeen, Maduka D. Ughasoro, Al-Mukhtar Y. Adamu, Oluwaseun Odeyinka, Taiwo Orimogunje, Ibrahim Maikore, et al.

    Employing malaria operational research (MOR) findings in planning national malaria control programmes is gaining increased attention. The malaria control foci are diverse, resources are limited; therefore, agreeing on priority areas is critical. Hitherto, the process of prioritising MOR questions in Nigeria has been limited to few stakeholders. In support of the National Malaria Elimination Programme’s (NMEP) effort at setting a MOR agenda, the Nigeria Field Epidemiology and Laboratory Training Programme (NFELTP) in collaboration with NMEP conducted preliminary exploratory study to identify key malaria research gaps and needs, and provide data to inform setting a robust national MOR agenda. The process of generating data is presented in this paper. A twelve-member task-team comprising NFELTP, university researchers and NMEP officers was commissioned. Following an inaugural meeting the task-team developed a framework of activities and held five planning meetings, conducted five-week online and self-administered paper-based surveys, key informant interview (KII), two-day desk review workshop, seven-day qualitative data analysis, ten-day result and five-day report writing workshops. Paired group members conducted the interviews across six geopolitical zones of Nigeria. Abridged study report was used for a two-day MOR setting agenda stakeholders’ workshop. A structured framework, study protocol and data collection instruments were developed and submitted for ethical approval. The instruments included survey questionnaire for detailed information on researchers and other stakeholders’ experience with MOR, the gaps and needs in thematic MOR areas; KII and Delphi guides. After an initial scoping review, primary data were collected from purposively selected survey participants using mixed methods: - online survey (n = 100), self-administered paper-based survey (n = 85), KII (n = 40), desk review workshop (n = 22) and Delphi interviews (n = 8). Comprehensive lists of research gaps/bottlenecks and needs were generated for each thematic area in malaria control. These were used at a two-day national MOR setting stakeholder workshop (n = 54) to guide the development of national MOR agenda document. A systematic approach involving broad stakeholder engagement provided data and evidence-based information for development of a robust national MOR agenda. The processes involved are recommended for use in malaria endemic settings.


  • Open Access

    Bottlenecks, concerns and needs in malaria operational research: the perspectives of key stakeholders in Nigeria

    by Pamela Onyiah, Al-Mukhtar Y. Adamu, Rotimi F. Afolabi, Olufemi Ajumobi, Maduka D. Ughasoro, Oluwaseun Odeyinka, Patrick Nguku, IkeOluwapo O. Ajayi

    We conducted a study to determine stakeholders’ perspective of the bottlenecks, concerns and needs to malaria operational research (MOR) agenda setting in Nigeria. Eighty-five (37.9%) stakeholders identified lack of positive behavioural change as the major bottleneck to MOR across the malaria thematic areas comprising of malaria prevention 58.8% (50), case management 34.8% (39), advocacy communication and social mobilisation 4.7% (4) while procurement and supply chain management (PSM) and programme management experts had the least response of 1.2% (1) each. Other bottlenecks were inadequate capacity to implement (13.8%, n = 31), inadequate funds (11.6%, n = 26), poor supply management (9.4%, n = 21), administrative bureaucracy (5.8%, n = 13), inadequacy of experts (1.3%, n = 3) and poor policy implementation (4.9%, n = 11). Of the 31 stakeholders who opined lack of capacity to execute malaria operational research; 17 (54.8%), 10 (32.3%), 3 (9.7%) and 1 (3.2%) were experts in case management, malaria prevention, surveillance, monitoring and evaluation and PSM respectively. Improvement in community enlightenment and awareness strategies; and active involvement of health care workers public and private sectors were identified solutions to lack of positive behavioural change.